Company intelligence / Profile preview

CDR PHARMA

Milan, Milan, Italy

Ownership: Private
Development stage: Other

Overview

CDR Pharma Srl is an Italian pharmaceutical and nutraceutical company focused on the development, production, and distribution of cardiovascular supplements, oral hygiene products, and dietary supplements. The company's commercial portfolio includes Gengyve, a mouthwash containing cetylpyridinium chloride and hyaluronic acid used to prevent plaque and gingivitis, and Maikol, a dietary supplement based on monacolin K for maintaining normal cholesterol levels. CDR Pharma is dedicated to providing high-quality, innovative healthcare solutions to improve patient well-being.

Therapeutic areas: Infectious DiseasesCardiovascular
Modalities: Small moleculePlant extractBotanical extract
Industry: Food & Nutrition

Beyond the preview

Go deeper on CDR PHARMA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CDR PHARMA.

Explore the full profile